Case number 1:18-cv-01926
Bayer Intellectual Property GMBH et al v. Teva Pharmaceuticals USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 2, 2020 | 18 | Order Dismissing Case (2) Docket Text: ORDER granting Stipulation of Dismissal [229] by Bayer and InvaGen. Signed by Judge Timothy Belcher Dyk on 9/2/2020. CASE CLOSED.Associated Cases: 1:17-cv-00462-TBD et al.(amf) |
| Mar 14, 2019 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Teva's Counterclaims to May 17, 2019 - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Mar 14, 2019 | 15 | Stipulation (4) Docket Text: STIPULATION [to Consolidate and Stay - (Teva)] by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 14, 2019 | 16 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER EXTENDING TIME to Answer Teva's Counterclaims to May 17, 2019. Signed by Judge Timothy Belcher Dyk on 3/14/2019. (nmg) |
| Mar 14, 2019 | 17 | Stipulation and Order (4) Docket Text: STIPULATION AND ORDER Consolidating and Staying Case re (15 in 1:18-cv-01926-TBD and 145 in 1:17-cv-00462-TBD). All papers shall be filed in Lead Case No. 17-462 TBD. (See order for further details). Signed by Judge Timothy Belcher Dyk on 3/14/2019. Associated Cases: 1:18-cv-01926-TBD, 1:17-cv-00462-TBD (nmg) |
| Mar 8, 2019 | 13 | Letter (1) Docket Text: Letter to The Honorable Timothy B. Dyk from Karen E. Keller - re Oral Order,, Set Hearings,. (Keller, Karen) |
| Mar 6, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Chandrika Vira, J.C. Rozendaal, and Michael Bruns for Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Feb 25, 2019 | 11 | Answer to Complaint (13) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc. by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd..(Keller, Karen) |
| Feb 25, 2019 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Feb 22, 2019 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Telephone Conference held on 2/22/2019. The 3-day Bench Trial scheduled to begin on 4/1/2019 is rescheduled to begin on 4/23/2019 in Courtroom 4A at the United States Court District Court for the District of Delaware, Wilmington, Delaware, with the testimony of one Bayer witness to be taken at a different time. The parties shall advise the court of that witnesss availability for trial by 5:00 PM on 2/27/2019. The Pre-Trial Conference set for 3/22/2019 is rescheduled for 3/20/2019 at 10:00 AM in Courtroom 203 at the United States Court of Appeals for the Federal Circuit, Washington, DC. Counsel for Bayer shall arrange for a court reporter. The parties shall file the Joint Proposed Final Pre-Trial Order by 5:00 PM on 3/15/2019. In No. 18-1926, the parties shall inform the court of the status of their discussions concerning consolidation and the possibility of a stipulation to stay the action and be bound by the final judgment of No. 17-462 by 5:00 PM on 3/8/2019 (*Court Reporter present) Associated Cases: 1:17-cv-00462-TBD, 1:18-cv-01926-TBD(ceg) |
| Feb 21, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A telephonic status conference has been scheduled for February 22, 2019 at 2:00 PM EASTERN TIME before Judge Timothy B. Dyk to discuss the status of the case. Counsel for Bayer shall initiate the teleconference call and arrange for a court reporter. Ordered by Judge Timothy B. Dyk on 2/19/2019. Associated Cases: 1:17-cv-00462-TBD, 1:18-cv-01926-TBD(ceg) |
| Feb 21, 2019 | 10 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting D.I. [9] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Chandrika Vira, and Michael Bruns. Signed by Judge Timothy Belcher Dyk on 2/21/2019. (nmg) |
| Feb 20, 2019 | 9 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Chandrika Vira, and Michael Bruns - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Feb 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Timothy Belcher Dyk of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (TBD) after the case number on all documents filed. Associated Cases: 1:17-cv-00462-TBD, 1:17-cv-00560-TBD, 1:17-cv-00584-TBD, 1:17-cv-01129-TBD, 1:18-cv-01926-TBD (rjb) |
| Dec 21, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME to Respond to the Complaint to February 25, 2019 (*Reset Answer Deadlines: Teva Pharmaceutical Industries Ltd. answer due 2/25/2019; Teva Pharmaceuticals USA, Inc. answer due 2/25/2019). Signed by Judge Richard G. Andrews on 12/21/2018. (nms) |
| Dec 20, 2018 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to February 25, 2019 - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Dec 12, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Dec 6, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 12/6/2018; Teva Pharmaceuticals USA, Inc. on 12/6/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Dec 6, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. Teva Pharmaceuticals USA, Inc. served on 12/6/2018, answer due 12/27/2018. (Blumenfeld, Jack) |
| Dec 5, 2018 | 1 | Exhibit A (14) |
| Dec 5, 2018 | 1 | Civil Cover Sheet (1) |
| Dec 5, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Dec 5, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/24/2018. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 4/24/2021. (lak) |
| Dec 5, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (lak) |
| Dec 5, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH filed by Bayer AG, Bayer Intellectual Property GMBH. (lak) |
| Dec 5, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (lak) |
| Dec 5, 2018 | 1 | Complaint* (1) |
